In Seizures in pregnant women with high blood pressure Magnista Injection is mostly used with other medicines to prevent and control seizures (fits) in pregnant women with high blood pressure. It can help reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. By controlling the frequency of seizures, it will help you go about your daily activities with more confidence. This medicine may take several weeks or months to work effectively as the dose is adjusted. Carefully follow all instructions and never take more tablets than your doctor tells you to. It needs to be taken regularly as prescribed to be most effective. In Decreased magnesium levels in blood Magnista Injection is also used to improve the level of magnesium in blood which is a very essential nutrient for carrying out various functions of our body. It has many benefits such as maintaining bone density and strength, calming the brain, relieving anxiety, and making you sleep better. It also helps to control blood sugar in people with diabetes and may lower the risk of developing diabetes. Additionally, it decreases abnormal heart rhythms and reduces premenstrual syndrome (PMS) symptoms such as abnormal cramps, mood swings, nausea, tiredness, or restlessness. Overall, it helps to improve your quality of life.
Caution is advised when consuming alcohol with Magnista Injection. Please consult your doctor.
Magnista Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life
Breast feeding : SAFE IF PRESCRIBED
Driving : CONSULT YOUR DOCTOR
Kidney : CAUTION
Liver : SAFE IF PRESCRIBED
If you miss a dose of Magnista Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More